# Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder

> **NCT04464148** · PHASE1 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Post Traumatic Stress Disorder
- Alcohol Use Disorder

## Interventions

- **DRUG:** Pregnenolone 250 mg
- **DRUG:** Pregnenolone 400 mg

## Key facts

- **NCT ID:** NCT04464148
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Feasibility study was not initiated.
- **Last updated:** 2021-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464148, "Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04464148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*